Study reveals potential benefits of naloxone in opioid-associated cardiac arrest

Patients who overdose on opioids and have a pulse are often given naloxone (Narcan) by first responders, a common life-saving measure.

J&J’s Rybrevant-chemo combo shows positive PFS data in confirmatory study

Johnson & Johnson’s Rybrevant met its primary endpoint in a Phase III confirmatory study testing the drug on patients with newly diagnosed advanced or metastatic

July 18, 2023

Sentara Health Taps RhythmX AI to Deploy Generative AI-Driven Co-Pilot for Clinicians

What You Should Know: RhythmX AI, a generative AI-native company driving revolutionary physician intelligence for whole-person care through cutting edge predictive and generative AI, announced

February 23, 2024

Biotech launches with $135 million for Vertex-competing pain medicine

After three years being incubated by California VC Westlake Village BioPartners, a new biotech launched Wednesday with $135 million and plans to compete with Vertex

February 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.